Side-by-side comparison of AI visibility scores, market position, and capabilities
Menlo Park YC AI sales training/enablement with 15x customer growth; $10.6M Series A Oct 2025 led by HubSpot founding CRO Stage 2 Capital/Lightbank; AI roleplays, RFP automation 80%+, deal AI agents competing with Highspot and Seismic.
Letter AI is a Menlo Park, California-based AI sales enablement platform — backed by Y Combinator with $10.6 million in total funding including a Series A in October 2025 led by Mark Roberge (HubSpot's founding CRO) at Stage 2 Capital with Lightbank, Y Combinator, Formus Capital, and Northwestern Mutual Future Ventures — providing B2B revenue teams with AI-native sales training, personalized coaching, AI roleplay simulations, customizable learning journeys, and an AI content hub that automates RFP responses, generating 80%+ question completion rates, and delivers deal-cycle AI agents that assist sellers in active customer engagements. Founded by Ali Akhtar and Armen Forget, Letter AI achieved 15x customer base growth with a 4-person team before the Series A.
Montreal zero-fee nonprofit fundraising platform with $1B+ processed; 100% donation pass-through via optional donor tips competing with Donorbox and Classy for nonprofit fundraising technology adoption.
Zeffy is a Montreal-based fundraising platform for nonprofit organizations that charges zero platform fees on donations — asking donors to optionally contribute a tip to cover Zeffy's operating costs rather than deducting fees from each donation, ensuring 100% of every donated dollar reaches the nonprofit cause. Founded in 2019 by Thibaut Davoult and Nicolas Lafleur, Zeffy has processed $1+ billion in nonprofit donations and provides a comprehensive suite including online donation forms, event ticketing, peer-to-peer fundraising campaigns, recurring donation management, and membership management — giving nonprofits a full fundraising platform at genuinely zero cost.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.